The manufacturer founders
call when they're serious.
PouchMade was built by operators who spent years watching the pouch category outgrow the manufacturers serving it. We started the company we wished existed when we were launching brands ourselves.
Why we built this.
The modern pouch category — energy, functional, hydration, wellness — emerged faster than the supply chain was built to support it. Founders with strong products and smart positioning kept running into the same wall: manufacturers with 16-week lead times, opaque costs, weak regulatory support, and zero interest in anything that looked like real R&D.
We started PouchMade to be the opposite of that. In-house R&D so formulations can actually be customized. cGMP facilities across three regions so brands can scale internationally. A regulatory team that knows the difference between PMTA and NDI submissions and stays current on state-level flavor laws. Transparent pricing. Honest timelines. Documentation that holds up to audit.
Thirty-plus brands launched. Five million cans shipped monthly. Thirty-plus countries served. Every batch tracked, every formulation documented, every launch on time.
Operating principles that shaped the company.
Speed is a product feature.
Every week a product isn't on shelf is a week a competitor ships something in its place. We organize our entire operation around compressing the time between a founder's first call and their first reorder.
Compliance is table stakes.
Regulatory expertise isn't a value-add — it's the floor. A manufacturer that gets your product pulled from shelves has cost you more than a slow one. We invest in the team and systems to keep your brand defensible.
Transparency builds trust.
Open costs. Honest timelines. Real production data. Founders can tell when they're being managed vs. partnered with, and so can their investors and retailers. We default to the former.
The pouch category is underbuilt.
There are dozens of pouch categories that don't exist yet — functional, adaptogenic, metabolic, clinical. The incumbents aren't investing in the R&D to build them. We are.
Three regions. One operating standard.
Our production and R&D footprint is distributed across North America, the United Kingdom, and continental Europe — so regional regulatory requirements are handled by teams in-region, and every customer gets the closest production path to their market.
North America
cGMP facility optimized for speed-to-market on U.S. launches. Registered for food, dietary supplement, and tobacco production. Houses our analytical chemistry lab and primary stability chambers.
United Kingdom
Advanced formulation capabilities, lead scientist team, and novel active development. Regulatory navigation for UK MHRA and broader European markets. Pilot-scale batching and consumer panel infrastructure.
Continental Europe
EU-region cGMP production line and pan-European distribution hub. Supports brands scaling into Germany, Sweden, France, the Nordics, and beyond. EU TPD compliance handled in-region.
Commitments we hold ourselves to.
Published externally because accountability only works when it's visible.
- 01We staff for quality before we staff for scale
- 02We say no to products we can't defend
- 03We share production data — good and bad
- 04We don't make deals we can't honor
- 05We pay suppliers on time, every time
- 06We treat founders like partners, not accounts
Let's make something.
A 30-minute call with our team tells you more than any RFP.